Objectives: We investigated the correlation between Japanese apricot (JA) intake and Helicobacter pylori-related chronic atrophic gastritis (CAG). Methods: A questionnaire was administered and serum anti-H. pylori IgG antibodies measured in 1358 asymptomatic adults. The subjects were divided into high-intake and low-intake groups. Histological and serological evaluation of H. pylori-related CAG was performed in 68 non-elderly volunteers. Results: The H. pylori-negative rate did not differ significantly between the high-intake and low-intake groups. Mean antibody titers were lower in the high-intake group, but the difference was not significant. There was no significant difference in the rate of H. pylori infection on the basis of JA intake when subjects were stratified by age. Among H. pylori-positive non-elderly subjects, antibody titers were significantly lower in the high-intake group (P ¼ 0.041). Endoscopic tissue biopsy from the 68 volunteers showed less H. pylori bacterial load and mononuclear infiltration irrespective of gastric site in the high-intake group. In the highintake group, antral neutrophil infiltration was significantly less pronounced and corporal atrophy was less extensive. Serological evaluation using serum PG levels also confirmed these histopathological data. Conclusions: Our findings strongly indicate a preventive effect of JA intake on CAG by inhibiting H. pylori infection and reducing active mucosal inflammation.
Introduction
It is now widely accepted that progression of chronic atrophic gastritis (CAG), including intestinal metaplasia, resulting from chronic active inflammation of the gastric mucosa by Helicobacter pylori infection is a primary mechanism of gastric carcinogenesis in areas of high cancer risk, including Japan (Correa and Houghton, 2007) . Although the pathogenic roles of H. pylori are not fully elucidated, H. pylori eradication leads to histological resolution of CAG, probably prevents progression of CAG and may reduce the incidence of gastric cancer (Kabir, 2009) . However, bacterial eradication in all H. pylori-infected patients remains difficult because of potential side effects, bacterial resistance to antibiotics and cost. Thus, it is important to find safe and inexpensive agents to control H. pylori-related CAG.
Progression of CAG is related to H. pylori bacterial factors such as VacA and CagA (Hatakeyama, 2004) , host factors like cytokine gene polymorphisms (El-Omar et al., 2000) and environmental factors. Environmental factors, particularly lifestyle and dietary habits, are the most frequent and direct factors to which the gastric mucosa is exposed and have a major effect on gastric carcinogenesis. For example, high sodium intake increases gastric mucosal inflammation and the risk of gastric cancer (Nozaki et al., 2002; Shikata et al., 2006) , and cigarette smoking is considered to be deeply involved in the transition of CAG to intestinal metaplasia and dysplasia (Kneller et al., 1992; Tredaniel et al., 1997) , which are precancerous conditions, in a model of gastric carcinogenesis postulated by Correa (Correa and Houghton, 2007) . Conversely, animal experiments and epidemiological studies have shown that vegetables, fruits and green tea lower the risk of gastric cancer (Yu et al., 1995; Kobayashi et al., 2002) .
Since ancient times, the Japanese apricot (JA) (Ume in Japanese; Prunus mume Siebold et Zucc.) has been known to possess various medical benefits. JA processed as an extract, dried or pickled, and made into liquor and soft drinks has been frequently prescribed as a traditional folk remedy for dyspepsia or gastrointestinal infections, including gastroenteritis, the common cold and quick recovery from general fatigue or a stiff neck. Although JA exerts various antibacterial and fungicidal properties, there is very little scientific proof about the effectiveness of JA in the treatment of the above-mentioned disorders. In an in vitro study by Fujita et al. (2002) , JA extracts had a bactericidal effect against H. pylori. More recently, Otsuka (2005) , in an in vivo study using H. pylori-infected Mongolian gerbils, reported that JA extracts have anti-H. pylori effects and lead to the improvement of H. pylori-induced CAG. These findings strongly suggest that JA contains constituents with anti-H. pylori effects. In this study, we investigated the effects of JA intake on H. pylori-related CAG in residents of Wakayama Prefecture, a well-known JA-growing region in Japan.
Methods
JA intake and H. pylori infection evaluated by serum antibody level This study recruited a total of 1358 adults (mean (s.d.) age: 54.6 (13.2) years; 586 men and 772 women) living in the Wakayama Prefecture, a well-known JA-growing region, who received annual medical check-ups provided by the local community health service. In Japan, these health check-up programs are performed in an effort to detect diseases at an early stage. Therefore, subjects who had specific symptoms requiring medical care were excluded from the program.
Symptom-free subjects underwent the following tests and procedures: physical examination, chest X-ray, electrocardiogram, blood laboratory tests, urinalysis, barium X-ray and fecal occult blood test. They also completed a selfadministered questionnaire and an interview to determine general health status. The questionnaire included an assessment of the daily intake of JA, either dried or pickled. The subjects were divided into two groups: high intake (X3 JA daily) and low intake (o3 JA daily). This classification is based on the results of a previous study analyzing the effects of a fruit-juice concentrate of JA (CJA) on H. pyloriinduced gastric lesions in Mongolian gerbils that indicated that daily intake of CJA of around 8.6 mg/day leads to a significant reduction in the number of infected H. pylori cells in the gastric epithelium and also an improvement in H. pylori-induced active gastritis (Otsuka, 2005) . On the basis of the comparison between the body weight of the Mongolian gerbils (50-60 g) and that of the study subjects (50-80 kg), and also on the fact that three JAs are equivalent to around 7.0 g of CJA on the basis of an analysis of citrate content, it is highly probable that daily intake of more than three JAs will exert the same effect in the human stomach as on gerbils.
In all these subjects, H. pylori IgG antibody titers were measured by ELISA (MBL Inc., Nagoya, Japan) as described elsewhere (Chen et al., 1997) . H. pylori antibody titers X30 U/ml were considered positive ( þ ) for H. pylori infection and those o30 U/ml were considered negative (À).
Correlation between JA intake and gastric mucosal histology We explained the protocol to 458 H. pylori-infected nonelderly subjects and invited them to participate in the study for the evaluation of the effects of JA intake on H. pylorirelated CAG. Of these potential subjects, 68 non-elderly (o65 years) individuals (mean (s.d.) age: 46.7 (8.2) years; 46 men and 22 women) agreed to participate and written informed consent to perform upper gastrointestinal tract endoscopy for histological assessment of CAG was obtained. In brief, endoscopic biopsy of the gastric corpus and antrum was performed (samples were obtained from two sites: one from the lesser curvature of the corpus 4 cm proximal to the gastric angle and the other from the lesser curvature of the antrum). The biopsy samples were embedded in paraffin, cut, stained with hematoxylin and eosin and examined histologically. Histopathological examination on the basis of the Sydney System (Dixon et al., 1996) included H. pylori bacterial load, neutrophil infiltration, mononuclear infiltration, atrophy and intestinal metaplasia. In addition, for serological evaluation of the extent of H. pylori-related CAG, the serum levels of pepsinogen-I and II (PG-I and PG-II) were measured using a modification (radioimmunoassay beads kit; Dainabott, Tokyo, Japan) of our previously reported radioimmunoassay (Ichinose et al., 1982) . Subjects with renal failure, history of gastrectomy or previous H. pylori eradication were not included in the analysis. No subject had been prescribed medication that might affect gastrointestinal function, such as proton pump inhibitors or non-steroidal anti-inflammatory drugs, before examination. The ethics committee of Wakayama Medical University approved the study protocols.
Statistical analysis
The data are expressed as mean±s.d. Data were analyzed using unpaired t-test and Fisher's exact text. The level Inhibitory effect of Japanese apricot on H. pylori S Enomoto et al of statistical significance was Po0.05. All analyses were performed using the SPSS 11.0 software package (SPSS Inc., Chicago, IL, USA).
Results
Correlation between JA intake and H. pylori infection In 1358 asymptomatic adults (mean (s.d.) age: 54.6 (13.2) years; 586 men and 772 women), serum anti-H. pylori antibody titers were measured for the evaluation of H. pylori infection. Table 1 shows the baseline data for subjects in the high-and low-JA-intake groups. There were no significant differences in age, gender or smoking habit between the two groups.
Comparison between the high-intake group (968 subjects) and the low-intake group (390 subjects) showed that the H. pylori-negative rate (H. pylori antibody titer o30 U/ml) did not differ significantly between the two groups (48.5 versus 48.2%) ( Table 1 ). In the high-intake as compared with the low-intake group, the mean H. pylori antibody titer was lower but the difference between groups was not statistically significant (Table 1) . We also stratified the subjects by age into non-elderly (30-64 years) and elderly (65-80 years) groups. In both elderly and non-elderly subjects, the H. pylori-negative rate and mean antibody titers did not differ significantly between the high-intake and the lowintake group (Table 1) .
Then we analyzed data from only the H. pylori-positive subjects (H. pylori antibody titer X30 U/ml; 701 subjects) (Figure 1 ). There was no significant difference in the serum H. pylori antibody titer level between the non-elderly and the elderly H. pylori-infected subjects. Among 243 elderly H. pylori-positive subjects, the H. pylori antibody titer did not differ significantly on the basis of JA intake (88.5 ± 60.6 U/ml versus 87.9±57.0 U/ml; P ¼ 0.945). However, in the 458 non-elderly H. pylori-positive subjects, the H. pylori antibody titers were significantly lower in the high-intake group (83.3 ± 54.8 U/ml versus 95.5 ± 64.6 U/ml; P ¼ 0.041) (Figure 1 ). In the subjects in the low-and high-intake groups, there was no significant difference in the antibody titer level between the two age groups. Effects of JA intake on H. pylori-related CAG Among the 68 non-elderly volunteers who had upper gastrointestinal endoscopy, 31 were in the high-JA-intake group and the remaining 37 were in the low-intake group. There were no significant inter-group differences in age, gender or smoking habit (Table 2) . We obtained gastric biopsy samples from the antrum and corpus from these subjects for histological evaluation of the gastric mucosa on the basis of the Sydney System for H. pylori bacterial load, neutrophil infiltration, mononuclear infiltration, atrophy and intestinal metaplasia (Table 3 ). There were no significant inter-group differences in the extent of intestinal metaplasia; Table 1 Clinico-serological features according to intake of JA (n ¼ 1358)
Total subjects
Low intake of Japanese apricot High intake of Japanese apricot Figure 1 Comparison of H. pylori antibody titers on the basis of JA intake, with stratification by age. In H. pylori-positive subjects (H. pylori antibody titer X30 U/ml), we compared H. pylori antibody titers according to JA intake, with stratification for age. In the elderly group (65-80 years), the H. pylori antibody titers did not differ significantly on the basis of JA intake (88.5 ± 60.6 U/ml versus 87.9 ± 57.0 U/ml; P ¼ 0.945). However, in the non-elderly group (30-64 years), the H. pylori antibody titers were significantly lower in the high-intake versus the low-intake group (83.3±54.8 U/ml versus 95.5±64.6 U/ml; P ¼ 0.041). JA, Japanese apricot.
Inhibitory effect of Japanese apricot on H. pylori S Enomoto et al however, in the high-intake group, the H. pylori bacterial load and mononuclear infiltration scores were significantly lower in both the antrum and corpus as compared with that in the low-intake group. In addition, the scores for neutrophil infiltration in the antrum and atrophy in the corpus were significantly lower. Serum PG was also measured in these volunteers (Table 2) . Serum PG-I did not significantly differ between the groups, but PG-II was significantly lower in the high-intake group (Po0.001). Hence, the PG-I/II ratio was higher in the high-intake group (Po0.001).
Discussion
Our study evaluated the histological and serological effects of JA intake on H. pylori-related CAG in residents of Wakayama Prefecture where more than 50% of Japan's JA is grown. The H. pylori-negative rate was not increased in the high-intake group. However, the overall, H. pylori antibody titers were lower, and in particular, they were significantly lower as compared with that in the low-intake group among the non-elderly (o65 years old) subjects. In general, higher H. pylori antibody titers correlate with more active H. pylorirelated CAG, as shown in clinical and animal studies (Eaton and Krakowka, 1992; Shimizu et al., 1999; Loffeld et al., 2000; Nozaki et al., 2002 ). In particular, in H. pylori-infected Mongolian gerbils, higher antibody titers are associated not only with more active gastritis, but also with a higher incidence of gastric cancer (Shimizu et al., 1999) . In light of these previous findings, our results suggest that although JA intake does not eradicate established H. pylori infection from the gastric mucosa, it may, by virtue of a direct bactericidal action on H. pylori and anti-inflammatory effects, decrease the severity of gastritis. Histological examination of endoscopic biopsy samples in the non-elderly subjects showed that, compared with the low-intake group, the high-intake group had significantly less H. pylori bacterial load, neutrophil infiltration and mononuclear infiltration in the gastric mucosa. As the histological effects of JA intake on H. pylori-related CAG were evaluated in a relatively small number of subjects, there is a potential for selection bias. However, the groups of subjects that underwent the analysis do not appear be significantly different from the original cohort, as indicated by the clinical features, except that they included more males. Therefore, these findings are strong histological evidence suggesting that JA intake inhibits H. pylori infection and can reduce H. pylori-related gastric mucosal inflammation. Furthermore, in the high-intake group, serum PG-II was significantly lower and the PG-I/II ratio was significantly higher as compared with that in the low-intake group. Serum PG-II reflects the activity of H. pylori-related gastritis (Plebani et al., 1996; Mardh et al., 2002) , and the PG-I/II ratio has been used as a marker for progression of CAG (Samloff et al., 1982;  Inhibitory effect of Japanese apricot on H. pylori S Enomoto et al Miki et al., 1987) . This also strongly suggests, from a serological perspective, that JA intake inhibits H. pylorirelated gastric mucosal inflammation and can effectively prevent the progression of CAG. In this study, among non-elderly subjects, the high-intake group had significantly lower H. pylori antibody titers, but among elderly subjects the H. pylori antibody titers did not differ significantly based on JA intake. This probably reflects the natural history of H. pylori infection. Compared with elderly subjects with more extensive CAG progression, nonelderly subjects have milder atrophy and higher inflammatory activity, so JA intake probably has a greater inhibitory effect. In other words, the earlier in life that eating JA is adopted, the greater the likelihood of preventing CAG progression and gastric cancer.
The mechanism by which JA inhibits H. pylori infection and reduces chronic gastritis activity is presently unknown. However, Miyazawa et al. (2006) report that ( þ )-syringaresinol, a lignan contained in JA extract, inhibits H. pylori motility. In addition, Fujita et al. (2002) found that JA extract has direct bactericidal activity against H. pylori. Thus, JA probably inhibits the progression of H. pylori-related CAG by a variety of mechanisms. Correa et al. have proposed a multistage model of carcinogenesis due to H. pylori infection (Correa and Houghton, 2007) in which CAG is a precancerous condition. According to this model, inhibiting progression to CAG can lead to prevention of gastric cancer, particularly intestinal-type gastric carcinoma. Meanwhile, along with others, we have reported that the incidence of gastric cancer increases gradually with CAG progression (Ohata et al., 2004; Yanaoka et al., 2008a) . Therefore, eating JA may be a promising strategy for prevention of gastric cancer.
We have reported that, besides progression of gastric mucosal atrophy, patients with severe gastric mucosal inflammation (high PG-II levels and/or high H. pylori antibody titers) are at high risk for gastric cancer, particularly diffuse-type carcinoma (Yanaoka et al., 2008b) , and that in these patients H. pylori eradication may likely prevent gastric cancer (Yanaoka et al., 2009) . In this study, the high-intake group had significantly lower H. pylori antibody titers and lower serum PG-II, suggesting that JA intake may be effective in preventing gastric cancer whose mechanism involves H. pylori-related active mucosal inflammation. Furthermore, Utsunomiya et al. (2005) reported that JA extract is effective in improving insulin resistance. Further studies are needed to confirm whether JA intake inhibits gastric carcinogenesis, but considering that hyperglycemia and insulin resistance are cancer risk factors (Yamagata et al., 2005; Becker et al., 2009) , JA intake, in addition to inhibiting CAG progression, may prevent gastric carcinogenesis via this latter route.
Our study has several limitations. Because JA has been considered to be a 'healthy' food with curative or beneficial effects, it is possible that those who have a higher intake of JA may be more likely to have a healthier lifestyle. Although we could not observe significant differences in smoking habits or the H. pylori-negative rate between the high-and low-JA intake groups, we cannot exclude the possibility of a secondary association with other unidentified lifestyle factors. Furthermore, the questionnaire in our study did not include an assessment of daily sodium intake for each subject, although high sodium intake enhances gastric mucosal inflammation and is thought to be involved in stomach carcinogenesis as a cancer promoter (Nozaki et al., 2002) . However, a simple questionnaire for sodium preference is by no means a reliable indicator of sodium intake in healthy subjects or hypertensive patients (Ohta et al., 2004; Hashimoto et al., 2008) . It is well known that JA itself, either dried or pickled, contains a high concentration of sodium (5-20% of net weight); therefore it is highly probable that the high-intake group is a non-sodium-conscious group and JA exerts a potent inhibitory effect on H. pylori-related gastritis, even in a group of subjects with high sodium intake.
Our study findings strongly suggest that JA has an inhibitory effect on the H. pylori-related active inflammation of the stomach and progression of CAG. This provides a sound basis for further investigation. In Japan, the most important issue in gastric cancer prevention is H. pylori infection, which is the major etiological factor in gastric carcinogenesis and which affects up to 60 million people. Promoting dietary habits that protect against gastric cancer, including JA intake, is probably an ideal alternative strategy for gastric cancer prevention. Thus, we are now conducting a follow-up study of the same subjects to analyze the relationship between JA intake and gastric cancer development.
